232 related articles for article (PubMed ID: 9354433)
1. PTEN/MMAC1 mutations in endometrial cancers.
Risinger JI; Hayes AK; Berchuck A; Barrett JC
Cancer Res; 1997 Nov; 57(21):4736-8. PubMed ID: 9354433
[TBL] [Abstract][Full Text] [Related]
2. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
[TBL] [Abstract][Full Text] [Related]
3. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles.
Kurose K; Bando K; Fukino K; Sugisaki Y; Araki T; Emi M
Jpn J Cancer Res; 1998 Aug; 89(8):842-8. PubMed ID: 9765621
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer.
Hirai Y; Tanaka N; Furuta R; Kawaguchi T; Sakamoto M; Shirahama S; Noda T
Gynecol Oncol; 2001 Oct; 83(1):81-8. PubMed ID: 11585417
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability and somatic mutations in endometrial carcinomas.
Sakamoto T; Murase T; Urushibata H; Kato K; Takada H; Imamura T; Mori H; Wake N
Gynecol Oncol; 1998 Oct; 71(1):53-8. PubMed ID: 9784319
[TBL] [Abstract][Full Text] [Related]
9. DCC genetic alterations and expression in endometrial carcinoma.
Ronnett BM; Burks RT; Cho KR; Hedrick L
Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
[TBL] [Abstract][Full Text] [Related]
10. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.
Ali IU; Schriml LM; Dean M
J Natl Cancer Inst; 1999 Nov; 91(22):1922-32. PubMed ID: 10564676
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
12. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
14. Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus.
Singh B; Ittmann MM; Krolewski JJ
Genes Chromosomes Cancer; 1998 Feb; 21(2):166-71. PubMed ID: 9491329
[TBL] [Abstract][Full Text] [Related]
15. Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome.
Marsh DJ; Roth S; Lunetta KL; Hemminki A; Dahia PL; Sistonen P; Zheng Z; Caron S; van Orsouw NJ; Bodmer WF; Cottrell SE; Dunlop MG; Eccles D; Hodgson SV; Järvinen H; Kellokumpu I; Markie D; Neale K; Phillips R; Rozen P; Syngal S; Vijg J; Tomlinson IP; Aaltonen LA; Eng C
Cancer Res; 1997 Nov; 57(22):5017-21. PubMed ID: 9371495
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
[TBL] [Abstract][Full Text] [Related]
17. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
18. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
Kurose K; Zhou XP; Araki T; Eng C
Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
[TBL] [Abstract][Full Text] [Related]
19. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
Velickovic M; Delahunt B; McIver B; Grebe SK
Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity of chromosome 3p sequences is an infrequent event in endometrial cancer.
Arlt MF; Herzog TJ; Mutch DG; Goodfellow PJ
Gynecol Oncol; 1996 Feb; 60(2):308-12. PubMed ID: 8631557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
